Beijing Konruns Pharmaceutical Co.,Ltd. (603590.SS)
CNY 25.56
(1.43%)
CNY 25.56
(1.43%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 3.78 Billion CNY | 10.4% |
| 2022 | 3.42 Billion CNY | 1.59% |
| 2021 | 3.37 Billion CNY | -10.95% |
| 2020 | 3.78 Billion CNY | 19.28% |
| 2019 | 3.17 Billion CNY | 8.69% |
| 2018 | 2.92 Billion CNY | 74.42% |
| 2017 | 1.67 Billion CNY | 63.77% |
| 2016 | 1.02 Billion CNY | 20.87% |
| 2015 | 845.8 Million CNY | 27.18% |
| 2014 | 665.04 Million CNY | 29.1% |
| 2013 | 515.12 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 3.99 Billion CNY | 2.24% |
| 2024 Q1 | 3.89 Billion CNY | 2.92% |
| 2024 Q2 | 3.9 Billion CNY | 0.44% |
| 2023 Q2 | 3.71 Billion CNY | 3.3% |
| 2023 FY | 3.78 Billion CNY | 10.4% |
| 2023 Q3 | 3.77 Billion CNY | 1.61% |
| 2023 Q4 | 3.78 Billion CNY | 0.11% |
| 2023 Q1 | 3.59 Billion CNY | 5.05% |
| 2022 Q3 | 3.35 Billion CNY | 0.52% |
| 2022 Q1 | 3.36 Billion CNY | -0.27% |
| 2022 FY | 3.42 Billion CNY | 1.59% |
| 2022 Q4 | 3.42 Billion CNY | 2.22% |
| 2022 Q2 | 3.33 Billion CNY | -0.86% |
| 2021 Q2 | 3.5 Billion CNY | -1.2% |
| 2021 FY | 3.37 Billion CNY | -10.95% |
| 2021 Q4 | 3.37 Billion CNY | -2.14% |
| 2021 Q3 | 3.44 Billion CNY | -1.79% |
| 2021 Q1 | 3.55 Billion CNY | -6.21% |
| 2020 Q3 | 3.77 Billion CNY | 13.6% |
| 2020 Q4 | 3.78 Billion CNY | 0.34% |
| 2020 FY | 3.78 Billion CNY | 19.28% |
| 2020 Q2 | 3.32 Billion CNY | 6.39% |
| 2020 Q1 | 3.12 Billion CNY | -1.65% |
| 2019 FY | 3.17 Billion CNY | 8.69% |
| 2019 Q4 | 3.17 Billion CNY | 2.64% |
| 2019 Q3 | 3.09 Billion CNY | 2.26% |
| 2019 Q1 | 2.99 Billion CNY | 2.57% |
| 2019 Q2 | 3.02 Billion CNY | 0.95% |
| 2018 Q4 | 2.92 Billion CNY | 3.84% |
| 2018 FY | 2.92 Billion CNY | 74.42% |
| 2018 Q1 | - CNY | -100.0% |
| 2018 Q2 | 1.86 Billion CNY | 0.0% |
| 2018 Q3 | 2.81 Billion CNY | 50.43% |
| 2017 Q4 | 1.67 Billion CNY | 0.0% |
| 2017 FY | 1.67 Billion CNY | 63.77% |
| 2016 Q4 | 1.02 Billion CNY | 0.0% |
| 2016 FY | 1.02 Billion CNY | 20.87% |
| 2016 Q2 | 906.86 Million CNY | 0.0% |
| 2015 FY | 845.8 Million CNY | 27.18% |
| 2014 FY | 665.04 Million CNY | 29.1% |
| 2013 FY | 515.12 Million CNY | 0.0% |